Active, Not Recruiting
AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission
NCT04062266
- Conditions
- Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, FLT3 Gene Mutation, +10 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States